MELANOSTATINE
™5
FOCUSING ON WHITENING
SKIN RADIANCE / SKIN LIGHTENING – WHITENING / ANTI-DARK SPOT
5 MELANOSTATINE FOCUSING ON WHITENING Mechanism of action - - PowerPoint PPT Presentation
SKIN RADIANCE / SKIN LIGHTENING WHITENING / ANTI-DARK SPOT 5 MELANOSTATINE FOCUSING ON WHITENING Mechanism of action Antagonist effect of Melanostatine 5 on camp Inhibition of Tyrosinase Inhibition
SKIN RADIANCE / SKIN LIGHTENING – WHITENING / ANTI-DARK SPOT
several physiological activities like pigmentation.
acid tyrosine to DOPA and catalyses its oxidation to DOPA-quinone.
melanocytes.
Decreases the melanin synthesis and blocks the melanin hyper-production through the inhibition of the MC1-R
The ideal skin lightening agent for cosmetic products is one that inhibits melanogenesis without cytotoxicity .
IC50 of Melanostatine™5 is 3.7nM
Melanostatine™5 antagonizes the signal transduction induced by 10-7M a-MSH
The tyrosinase activity is detected with a Western blot. Tyrosine is labelled by specific anti-tyrosinase monoclonal antibody. Melanostatine™5 blocks the melanogenesis pathway and inhibits tyrosinase activity and melanin synthesis
Melanostatine™5 inhibits the synthesis of melanin induced by α-MSH by 33%
The total proteins content + melanin synthesis were determined by the colorimetric method Pierce BCA (Bicinchoninic Acid) Protein Assay
α-MSH : numerous highly DOPA- positive melanocytes α-MSH + MELANOSTATINE™5: less DOPA-positive melanocytes
These microscope images demonstrate that Melanostatine™5 does not interfere with the melanocyte’s functions. However when melanocytes are stimulated, Melanostatine™5 opposes the hyperproduction of melanin.
Test protocol 50 Asian (female) volunteers applied a whitening cream containing 2% TyrostatTM- 11 and 4% Melanostatine™5, 2x/day for 4 weeks.
With complementary and synergic pathways, TyrostatTM-11 and Melanostatine™5 reduce sun spots, freckles and uneven pigmentation allowing a lighter and luminous skin tone.
New concept in the inhibition of Melanogenesis Hyper-Stimulation
Recommended dosage: 4 – 8% Potential Applications: Incorporation: at the end of the formulation (35/40˚C), pH:5-7 INCI name: Water (and) Dextran (and) Nonapeptide-1
(foundation-powder)